Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Shuqun Yang
Introduction
Shuqun Yang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating various types of cancer and other diseases. His work exemplifies the intersection of innovation and medical research.
Latest Patents
Shuqun Yang holds a patent for an N-(azaaryl)cyclolactam-1-carboxamide derivative. This patent includes a preparation method and its applications. The compound is designed to be used in the preparation of drugs for treating cancer, tumors, autoimmune diseases, metabolic diseases, and metastatic diseases. Specifically, it has potential applications in treating ovarian cancer, pancreatic cancer, prostate cancer, breast cancer, cervical cancer, glioblastoma, multiple myeloma, and neurodegenerative diseases. The compounds are expected to contribute to the development of a new generation of CSF-1R inhibitor drugs.
Career Highlights
Shuqun Yang is currently associated with Abbisko Therapeutics Co., Ltd. His role in the company allows him to further his research and development efforts in the pharmaceutical industry. His innovative work has positioned him as a key figure in the quest for effective cancer treatments.
Collaborations
Shuqun Yang collaborates with esteemed colleagues such as Baowei Zhao and Mingming Zhang. Their combined expertise enhances the research and development efforts at Abbisko Therapeutics Co., Ltd.
Conclusion
Shuqun Yang's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts highlight the importance of research in developing new treatments for serious diseases. His work continues to pave the way for advancements in cancer therapy and beyond.